Please assess the completion status of the following clinical trial:

Trial Title: Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular Degeneration

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* choroidal neovascularization caused by age-related macula degeneration~* no previous treatment~* a follow-up at least 12 months~* a baseline visual acuity ranging from a letter score of 0 to 70 on the Early Treatment Diabetic Retinopathy Study chart~Exclusion Criteria:~* choroidal neovascularization caused by other eye diseases~* ocular surgery within the past 3 mouths~* history of uveitis~* intraocular pressure higher than 25 mmHg, or glaucoma~* history of systemic or ocular thromboembolic events.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Bevacizumab (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).